Menu
Skip to content
About Us
Investment Focus
Team
Portfolio
News
Contact Us
Foamix Pharmaceuticals Ltd. Announces Closing of its $69 Million Public Offering of Ordinary Shares
Foamix Pharmaceuticals Ltd. Announces Closing of its $69 Million Public Offering of Ordinary SharesÂ